Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page
- Check4 days agoChange DetectedThe Record History gains a new entry for Revision: v3.6.3. This signals a subsequent update to the study record's metadata on ClinicalTrials.gov.SummaryDifference0.1%

- Check11 days agoChange DetectedThe record history adds a new revision entry for Revision: v3.6.2, indicating the page was updated from v3.6.0 to v3.6.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history page now includes new quick-links (Check who can join, Find Contact Information) and displays an updated Study Status entry in the version list, reflecting interface enhancements to access study details.SummaryDifference1%

- Check32 days agoChange DetectedA new site revision entry (v3.5.5) was added to the history, and the previous revision (v3.5.4) was removed from the record.SummaryDifference0.1%

- Check53 days agoChange DetectedA new revision entry, v3.5.4, has been added to the Record History. The previous revision, v3.5.3, has been removed from the list, reflecting an update to the page's release notes.SummaryDifference0.1%

- Check60 days agoChange DetectedNo textual changes are present in the supplied data for this page. The input contains no additions or deletions to summarize.SummaryDifference0.1%

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.